658 related articles for article (PubMed ID: 7563486)
1. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
2. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
3. Germ-line mutations in nonsyndromic pheochromocytoma.
Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
[TBL] [Abstract][Full Text] [Related]
4. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
[TBL] [Abstract][Full Text] [Related]
7. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
8. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
[TBL] [Abstract][Full Text] [Related]
11. Genetic aspects of pheochromocytoma.
Koch CA; Vortmeyer AO; Huang SC; Alesci S; Zhuang Z; Pacak K
Endocr Regul; 2001 Mar; 35(1):43-52. PubMed ID: 11308996
[TBL] [Abstract][Full Text] [Related]
12. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
Assadi F; Brackbill EL
Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
[TBL] [Abstract][Full Text] [Related]
13. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes.
Bar M; Friedman E; Jakobovitz O; Leibowitz G; Lerer I; Abeliovich D; Gross DJ
Clin Endocrinol (Oxf); 1997 Dec; 47(6):707-12. PubMed ID: 9497878
[TBL] [Abstract][Full Text] [Related]
14. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
16. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.
Hofstra RM; Stelwagen T; Stulp RP; de Jong D; Hulsbeek M; Kamsteeg EJ; van den Berg A; Landsvater RM; Vermey A; Molenaar WM; Lips CJ; Buys CH
J Clin Endocrinol Metab; 1996 Aug; 81(8):2881-4. PubMed ID: 8768845
[TBL] [Abstract][Full Text] [Related]
17. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients.
Januszewicz A; Neumann HP; Loń I; Szmigielski C; Symonides B; Kabat M; Apel TW; Wocial B; Lapiński M; Januszewicz W
J Hypertens; 2000 Aug; 18(8):1019-23. PubMed ID: 10953992
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing for pheochromocytoma-associated syndromes.
Pawlu C; Bausch B; Reisch N; Neumann HP
Ann Endocrinol (Paris); 2005 Jun; 66(3):178-85. PubMed ID: 15988378
[TBL] [Abstract][Full Text] [Related]
20. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
